Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235365
Status:
WITHDRAWN
Last Update Posted:
2012-11-22
First Post:
2005-10-07
Brief Title:
Metacognitive Therapy for Comorbid Insomnia
Sponsor:
Norwegian University of Science and Technology
Organization:
Norwegian University of Science and Technology
Study Overview
Official Title:
Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia
Status:
WITHDRAWN
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
problems recruiting patients
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia
Detailed Description:
This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia The patients will be randomized into two groups of 25 patients The first group receives meta-cognitive therapy whereas the second group will be assigned to a waiting list control
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None